Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAMELLIA-TIMI 61
NCT02019264Phase 4Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jan 2014
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 4 trial of lorcaserin in obesity, Overweight, sponsored by Eisai Co., Ltd.. Started Jan 2014; status: completed.
02
Drugs
lorcaserin
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT02019264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02019264.